Protection against experimental P. falciparum malaria is associated with short AMA-1 peptide analogue α-helical structures

Biochimie

Volumn 84, Issue 12, 2002, Pages 1181-1188

  Cubillos, Marcia ^a   Salazar, Luz Mary ^a   Torres, Libardo ^b   Patarroyo, Manuel Elkin ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

AMA 1 protein; Conformation; Malaria; NMR; Peptides

Indexed keywords

AMINO ACID; APICAL MEMBRANE ANTIGEN 1; MALARIA VACCINE; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PEPTIDE; PEPTIDE 20032; PEPTIDE 20034; PEPTIDE 4325; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; ERYTHROCYTE; GEOMETRY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MALARIA FALCIPARUM; MOLECULAR DYNAMICS; MONKEY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PAIRED HELICAL FILAMENT; PEPTIDE ANALYSIS; PLASMODIUM FALCIPARUM; RESIDUE ANALYSIS;

PLASMODIUM FALCIPARUM;

EID: 0036964043     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00002-6     Document Type: Article

References (27)

1. B. Greenwood, T. Mutabingwa, Malaria in 2002, Nature 415 (2002) 670-672.
2. T.L. Richie, A. Saul, Progress and challenges for malaria vaccines, Nature 415 (2002) 694-701.
3. D.L. Narum, A.W. Thomas, Differential localisation of full-length and processed forms of PF83/AMA-1 anapical membrane antigen of Plasmodium falciparum merozoites, Mol. Biochem. Parasitol. 67 (1994) 59-68.
4. M. Urquiza, J.E. Suarez, C. Cardenas, R. Lopez, A. Puentes, F. Chavez, J.C. Calvo, M.E. Patarroyo, Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein, Vaccine 19 (2002) 508-513.
5. M.F. Good, D. Pombo, I.A. Quakyi, E.M. Riley, R.A. Houghten, A. Menon, D.W. Alling, J.A. Berzofsky, L.H. Miller, Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule, Proc. Natl. Acad. Sci. USA 85 (1988) 1199-1203.
6. M. Aidoo, A. Lalvani, C.E. Allsopp, M. Plebanski, S.J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, F. Gotch, D.A. Fidock, M. Takiguchi, K.J.H. Robson, B.M. Greenwood, P. Druilhe, H.C. Whittle, A.V. Hill, Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria, Lancet 345 (1995) 1003-1006.
7. M.F. Good, S. Kumar, L.H. Miller, The real difficulties for malaria sporozoite vaccine development: Nonresponsiveness and antigenic variation, Immunol. Today 9 (1988) 351-357.
8. R.A. Houghten, General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids, Proc. Natl. Acad. Sci. USA 82 (1985) 5131-5135.
9. R. Rodriguez, A. Moreno, F. Guzman, M. Calvo, M.E. Patarroyo, Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum, Am. J. Trop. Med. Hyg. 43 (1990) 339-354.
10. C. Lambros, J.P. Vandenberg, Synchronization of Plasmodium falciparum erythrocytic stages in culture, J. Parasitol. 65 (1979) 418-420.
11. M.S. Blake, K.H. Johnston, G.J. Russell-Jones, E.C. Gotschlich, A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-body on Western blots, Anal. Biochem. 136 (1984) 175-179.
12. T.P. Pitner, D.W. Urry, Proton magnetic resonance studies in trifluoroethanol. Solvent mixtures as a means of delineating peptide protons, J. Am. Chem. Soc. 94 (1972) 1399-1400.
13. J. Evans, Biomolecular NMR Spectroscopy, Oxford University Press, New York, 1995 pp. 153-154.
14. M. Rance, O.W. Soressen, G. Bodenhausen, G. Wagner, R.R. Ernst, K. Wüthrich, Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering, Biochem. Biophys. Res. Commun. 117 (1983) 479-485.
15. A. Bax, D.G. Davis, MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy, J. Magn. Reson. 65 (1985) 355-360.
16. K. Wüthrich, NMR of Proteins and Nucleic Acids, John Wiley & Sons, New York, 1986.
17. J. Jeener, B.H. Meier, P. Backman, R.R. Ernst, Investigation of exchange processes by two-dimensional NMR spectroscopy, J. Chem. Phys. 71 (1979) 4546-4553.
18. W. Kabsch, C. Sander, Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features, Biopolymers 22 (1983) 2577-2637.
19. U. Zügel, R. Wang, G. Shih, A. Sette, J. Alexander, H.M. Grey, Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues, J. Immunol. 161 (1998) 1705-1709.
20. J.A. Bristol, J. Schlom, S.I. Abrams, Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties, J. Immunol. 160 (1998) 2433-2441.
21. D.A. Ostrov, M.R. Matthew, W. Shi, E. Palmieri, G.J. Christianson, L. Mendoza, G. Villaflor, D. Tilley, N. Shastri, H. Grey, S.C. Almo, D. Roopenian, S.G. Nathenson, How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-non-self discrimination, J. Immunol. 168 (2002) 283-289.
22. S. Tangri, G.Y. Ishioka, X. Huang, J. Sidney, S. Southwood, J. Fikes, A. Sette, Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide, J. Exp. Med. 194 (2001) 833-846.
23. B.E. Willcox, G.F. Gao, J.R. Wyer, J.E. Ladbury, J.I. Bell, B.K. Jakobsen, P.A. Van Der Merwe, TCR binding to peptide-MHC stabilizes a flexible recognition interface, Immunity 10 (1999) 357-365.
24. K. Piotr, R. Pacholczyk, H. Ignatowicz, P. Kisielow, P.L. Jensen, L. Ignatowicz, Positive selection of CD4(+) T cells is induced in vivo by agonist and inhibited by antagonist peptides, J. Exp. Med. 194 (2001) 404-416.
25. F. Espejo, M. Cubillos, L.M. Salazar, F. Guzman, M. Urquiza, M. Ocampo, Y. Silva, R. Rodriguez, E. Lioy, M.E. Patarroyo, Structure, immunogenicity, and protectivity relationship for the 1585 malarial peptide and its substitution analogues, Angew. Chem. Int. Ed. 40 (2001) 4654-4657.
26. J. Purmova, L.M. Salazar, F. Espejo, M.H. Torres, M. Cubillos, E. Torres, Y. Lopez, R. Rodriguez, M.E. Patarroyo, NMR structure of Plasmodium falciparum malaria peptide correlates with protective immunity, Biochim. Biophys. Acta 1571 (2002) 27-33.
27. L.M. Salazar, M.P. Alba, M.H. Torres, M. Pinto, X. Cortes, L. Torres, M.E. Patarroyo, Protection against experimental malaria associated with AMA-1 peptide analogue structures, FEBS Lett. 527 (2002) 95-100.